The Abnormal Cytotoxic T Cell Response to Epstein-Barr Virus in Rheumatoid Arthritis is Correlated with Disease Activity and Occurs in Other Arthropathies

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 1986 Nov 1

PMID 2878645

Citations 9

Authors

J S Gaston

A B Rickinson

Q Y Yao

M A Epstein

Affiliations

Soon will be listed here.

Abstract

The cytotoxic T cell response to Epstein-Barr virus as measured by the regression assay was found to be impaired in a group of patients with active rheumatoid arthritis (RA). When these patients responded clinically to treatment with sulphasalazine there was a concomitant increase in the strength of this virus specific T cell response. The suggestion of a correlation between disease activity and impairment in this immune response was borne out in studies of other groups of patients with RA. Thus six out of 10 hospitalised patients had abnormal regression compared with six out of 31 patients seen routinely as outpatients. Studies of patients with inflammatory arthropathies other than RA, however, also showed abnormal regression in four out of 16 patients. It is concluded that the impairment in the cytotoxic T cell response to Epstein-Barr virus in RA is influenced by disease activity, and that this abnormality is not a specific feature of rheumatoid disease.

Citing Articles

Epstein-Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases.

Zhao Y, Zhang Q, Zhang B, Dai Y, Gao Y, Li C Int J Mol Sci. 2024; 25(15).

PMID: 39125729 PMC: 11311853. DOI: 10.3390/ijms25158160.

At Early Rheumatoid Arthritis Stage, the Infectious Spectrum Is Driven by Non-Familial Factors and Anti-CCP Immunization.

Arleevskaya M, Novikov A, Valeeva A, Korovina M, Serdiuk I, Popov V J Clin Med. 2024; 13(10).

PMID: 38792338 PMC: 11122272. DOI: 10.3390/jcm13102796.

Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients.

Saito S, Takeuchi T J Clin Exp Hematop. 2019; 59(4):145-155.

PMID: 31866617 PMC: 6954173. DOI: 10.3960/jslrt.19028.

How Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and Viruses.

Arleevskaya M, Kravtsova O, Lemerle J, Renaudineau Y, Tsibulkin A Front Microbiol. 2016; 7:1296.

PMID: 27582741 PMC: 4987382. DOI: 10.3389/fmicb.2016.01296.

High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis?.

Thomas R, Turner M, Cope A Arthritis Res Ther. 2008; 10(4):210.

PMID: 18710589 PMC: 2575618. DOI: 10.1186/ar2446.

References

Moss D, Rickinson A, Pope J . Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int J Cancer. 1979; 23(5):618-25. DOI: 10.1002/ijc.2910230506. View

Rickinson A, Moss D, Pope J . Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. Int J Cancer. 1979; 23(5):610-7. DOI: 10.1002/ijc.2910230505. View

Bardwick P, Bluestein H, Zvaifler N, Depper J, Seegmiller J . Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum. 1980; 23(6):626-32. DOI: 10.1002/art.1780230603. View

Rickinson A, Moss D, Pope J, Ahlberg N . Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients. Int J Cancer. 1980; 25(1):59-65. DOI: 10.1002/ijc.2910250108. View

Alspaugh M, Henle G, Lennette E, Henle W . Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest. 1981; 67(4):1134-40. PMC: 370674. DOI: 10.1172/jci110127. View

Depper J, Zvaifler N . Epstein-Barr virus. Its relationship to the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 1981; 24(6):755-61. DOI: 10.1002/art.1780240601. View

Tosato G, Steinberg A, Blaese R . Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med. 1981; 305(21):1238-43. DOI: 10.1056/NEJM198111193052102. View

Depper J, Bluestein H, Zvaifler N . Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol. 1981; 127(5):1899-902. View

Rickinson A, Moss D, Wallace L, Rowe M, Misko I, Epstein M . Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res. 1981; 41(11 Pt 1):4216-21. View

10.

Venables P, Roffe L, Erhardt C, Maini R, Edwards J, PORTER A . Titers of antibodies to RANA in rheumatoid arthritis and normal sera. Relationship to Epstein-Barr virus infection. Arthritis Rheum. 1981; 24(12):1459-68. DOI: 10.1002/art.1780241201. View

11.

Martin M, Dieppe P, Jones H, Warren C, Whicher J, Kohn J . Serum concanavalin-A binding in rheumatoid arthritis. Ann Rheum Dis. 1982; 41(2):133-6. PMC: 1000896. DOI: 10.1136/ard.41.2.133. View

12.

Gaston J, Rickinson A, Epstein M . Epstein-Barr-virus-specific T-cell memory in renal-allograft recipients under long-term immunosuppression. Lancet. 1982; 1(8278):923-5. DOI: 10.1016/s0140-6736(82)91930-4. View

13.

Bird H, Dixon J, Pickup M, Rhind V, Lowe J, Lee M . A biochemical assessment of sulphasalazine in rheumatoid arthritis. J Rheumatol. 1982; 9(1):36-45. View

14.

Gaston J, Rickinson A, Epstein M . Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients. Rheumatol Int. 1982; 2(4):155-9. DOI: 10.1007/BF00286137. View

15.

Moss D, Klestov A, Burrows S, Kane R . A comparison of Epstein-Barr virus-specific T-cell immunity in rheumatoid arthritis and osteoarthritis patients. Aust J Exp Biol Med Sci. 1983; 61 ( Pt 5):509-16. DOI: 10.1038/icb.1983.48. View

16.

Sculley T, Walker P, Moss D, Pope J . Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis. J Virol. 1984; 52(1):88-93. PMC: 254493. DOI: 10.1128/JVI.52.1.88-93.1984. View

17.

Yao Q, Rickinson A, Gaston J, Epstein M . In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients. Int J Cancer. 1985; 35(1):43-9. DOI: 10.1002/ijc.2910350108. View

18.

Bax D, Amos R . Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate. Ann Rheum Dis. 1985; 44(3):194-8. PMC: 1001604. DOI: 10.1136/ard.44.3.194. View

19.

Irving W, Walker P, Lydyard P . Abnormal responses of rheumatoid arthritis lymphocytes to Epstein-Barr virus infection in vitro: evidence for multiple defects. Ann Rheum Dis. 1985; 44(7):462-8. PMC: 1001677. DOI: 10.1136/ard.44.7.462. View

20.

Yao Q, Rickinson A, Gaston J, Epstein M . Disturbance of the Epstein-Barr virus-host balance in rheumatoid arthritis patients: a quantitative study. Clin Exp Immunol. 1986; 64(2):302-10. PMC: 1542331. View